Andree Yeramian Hakim
Grado: Doctor/a
973 70 36 67
andree.yeramian(ELIMINAR)@udl.cat
ResearcherID: http://www.researcherid.com/rid/B-5936-2009
Publicaciones
-
Bergadà L; Sorolla A; Yeramian A; Eritja N; Mirantes C; Matias-Guiu X; Dolcet X
Combination of Vorinostat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells
MOLECULAR ONCOLOGY 7 763-775. .
-
Eritja N; Mirantes C; Llobet D; Yeramian A; Bergadà L; Dosil MA; Domingo M; Matias-Guiu X; Dolcet X
Long-Term Estradiot Exposure Is a Direct Mitogen for Insulin/EGF-Primed Endometriat Cells and Drives PTEN Loss-Induced Hyperplasic Growth
AMERICAN JOURNAL OF PATHOLOGY 183 277-287. .
-
Yeramian A; Moreno-Bueno G; Dolcet X; Catasus L; Abal M; Colas E; Reventos J; Palacios J; Prat J; Matias-Guiu X
Endometrial carcinoma: molecular alterations involved in tumor development and progression
ONCOGENE 32 403-413. .
-
Sorolla, Anabel; Yeramian, Andree; Valls, Joan; Dolcet, Xavier; Bergada, Laura; Llombart-Cussac, Antoni; Maria Marti, Rosa; Matias-Guiu, Xavier
Blockade of NF kappa B activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells
MOLECULAR ONCOLOGY 6 530-541. .
-
MARTI LABORDA, ROSA MARIA; Sorolla A; Yeramian A
New therapeutic targets in melanoma.
ACTAS DERMO-SIFILIOGRAFICAS 103 579-590. .
-
Yeramian, Andree; Sorolla, Anabel; Velasco, Ana; Santacana, Maria; Dolcet, Xavier; Valls, Joan; Abal, Leandre; Moreno, Sara; Egido, Ramon; Casanova, Josep M.; Puig, Susana; Vilella, Ramon; Llombart-Cussac, Antonio; Matias-Guiu, Xavier; Marti, Rosa M.
Inhibition of activated receptor tyrosine kinases by Sunitinib induces growth arrest and sensitizes melanoma cells to Bortezomib by blocking Akt pathway
INTERNATIONAL JOURNAL OF CANCER 130 967-978. .
-
Santacana, Maria; Yeramian, Andree; Velasco, Ana; Bergada, Laura; Gatius, Sonia; Garcia, Virginia; Azueta, Ainara; Palacios, Jose; Dolcet, Xavier; Oliva, Esther; Matias-Guiu, Xavier
Immunohistochemical features of post-radiation vaginal recurrences of endometrioid carcinomas of the endometrium: role for proteins involved in resistance to apoptosis and hypoxia
Histopathology 60 460-471. .
-
Yeramian, Andree; Santacana, Maria; Sorolla, Anabel; Llobet, David; Encinas, Mario; Velasco, Ana; Bahi, Nuria; Eritja, Nuria; Domingo, Monica; Oliva, Esther; Dolcet, Xavier; Matias-Guiu, Xavier
Nuclear factor-?B2/p100 promotes endometrial carcinoma cell survival under hypoxia in a HIF-1a independent manner.
LABORATORY INVESTIGATION 91 859-871. .
-
Llobet, David; Eritja, Nuria; Domingo, Monica; Bergada, Laura; Mirantes, Cristina; Santacana, Maria; Pallares, Judit; Macia, Anna; Yeramian, Andree; Encinas, Mario; Moreno-Bueno, Gema; Palacios, Jose; Lewis, Robert E.; Matias-Guiu, Xavier; Dolcet, Xavi
KSR1 is overexpressed in endometrial carcinoma and regulates proliferation and TRAIL-induced apoptosis by modulating FLIP levels.
AMERICAN JOURNAL OF PATHOLOGY 178 1529-1543. .
-
Velasco, Ana; Pallares, Judit; Santacana, Maria; Gatius, Sonia; Fernandez, Melisa; Domingo, Monica; Valls, Joan; Yeramian, Andree; Encinas, Mario; Dolcet, Xavier; Matias-Guiu, Xavier
Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma.
HUMAN PATHOLOGY 42 185-193. .
-
Eritja, Nuria; Llobet, David; Domingo, Monica; Santacana, Maria; Yeramian, Andree; Matias-Guiu, Xavier; Dolcet, Xavi
A novel three-dimensional culture system of polarized epithelial cells to study endometrial carcinogenesis.
AMERICAN JOURNAL OF PATHOLOGY 176 2722-2731. .
-
Llobet, D.; Eritja, N.; Yeramian, A.; Pallares, J.; Sorolla, A.; Domingo, M.; Santacana, M.; Gonzalez-Tallada, F. J.; Matias-Guiu, X.; Dolcet, X.
The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms.
EUROPEAN JOURNAL OF CANCER 46 836-850. .
Proyectos
- ¿CONOCER LA PREDISPOSICION GENETICA DEL PACIENTE CON OBESIDAD AYUDA A MEJORAR LA EFICACIA DE LA CIRUGÍA BARIÁTRICA?
- Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
- La serine/threonine protein kinase PRK1 en l'adipòcit de pacients amb diabetes (Ajut per a la recerca de la Societat Catalana d'Endocrinologia i Nutrició)
- CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UN DOCTOR PER LA REALITZACIO DE L'ESTUDI DE LA FUNCIO PULMONAR I LA RESPIRACIO DURANT LA NIT: DUES NOVES PREOCUPACIONS PER LA DIABETIS MELLITUS TIPUS 2.
- ESTUDIO DE LA HETEROGENEIDAD TUMORAL EN EL MELANOMA
- DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
- Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment
- Estudio metabolómico del carcinoma de endometrio en relación a parametros morfológicos y moleculares
- EXPRESION DE CANALES DE CALCIO DE TIPO T EN NEOPLASIAS MELANOCÍTICAS BENIGNAS Y MALIGNAS. EVALUACION DE SU APLICICABILIDAD CLINICA COMO DIANAS TERAPEUTICAS EN EL MELANOMA
- Alteraciones moleculares relacionados con la progresión tumoral en el cáncer de endometrio
- MECANISMOS DE REGULACION FLIP Y LA RESPUESTA A TRAIL EN EL DESARROLLO Y PROGRESION DEL CANCER
- Caracterización de las células neoplásicas inmaduras pluripotenciales (células madre neoplásicas) en el cáncer de endometrio. Implicaciones Patogénicas, pronósticas y terapeuticas
